D
Greenwich LifeSciences, Inc. GLSI
$11.67 -$0.26-2.18% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -17.99M -16.57M -15.79M -10.50M -10.22M
Total Depreciation and Amortization 3.60K 3.60K 3.60K 3.60K 3.60K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 9.15M 8.20M 7.25M 2.38M 2.38M
Change in Net Operating Assets 332.60K 1.05M 1.27M 545.10K 1.05M
Cash from Operations -8.50M -7.32M -7.27M -7.57M -6.79M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 4.40M 4.56M 4.37M 4.25M 3.07M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 4.40M 4.56M 4.37M 4.25M 3.07M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -4.10M -2.76M -2.90M -3.32M -3.72M